BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 18154953)

  • 1. Toxoplasma gondii: evaluation of an intranasal vaccine using recombinant proteins against brain cyst formation in BALB/c mice.
    Igarashi M; Kano F; Tamekuni K; Machado RZ; Navarro IT; Vidotto O; Vidotto MC; Garcia JL
    Exp Parasitol; 2008 Mar; 118(3):386-92. PubMed ID: 18154953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective activity against oocyst shedding in cats vaccinated with crude rhoptry proteins of the Toxoplasma gondii by the intranasal route.
    Garcia JL; Navarro IT; Biazzono L; Freire RL; da Silva Guimarães Junior J; Cryssafidis AL; Bugni FM; da Cunha IA; Hamada FN; Dias RC
    Vet Parasitol; 2007 Apr; 145(3-4):197-206. PubMed ID: 17296268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.
    Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H
    Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial protection against tissue cysts formation in pigs vaccinated with crude rhoptry proteins of Toxoplasma gondii.
    Garcia JL; Gennari SM; Navarro IT; Machado RZ; Sinhorini IL; Freire RL; Marana ER; Tsutsui V; Contente AP; Begale LP
    Vet Parasitol; 2005 May; 129(3-4):209-17. PubMed ID: 15845275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice.
    Dziadek B; Gatkowska J; Grzybowski M; Dziadek J; Dzitko K; Dlugonska H
    Exp Parasitol; 2012 May; 131(1):133-8. PubMed ID: 22445587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intranasal immunization with mucosal complex vaccine protects mice against Toxoplasma gondii].
    Yin GR; Meng XL; Ma GY; Ma XM
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Aug; 25(4):290-4. PubMed ID: 18038798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxoplasma gondii: the immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis.
    Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Dlugonska H
    Exp Parasitol; 2009 Sep; 123(1):81-9. PubMed ID: 19508869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxoplasma gondii: protective effect of an intranasal SAG1 and MIC4 DNA vaccine in mice.
    Wang H; He S; Yao Y; Cong H; Zhao H; Li T; Zhu XQ
    Exp Parasitol; 2009 Jul; 122(3):226-32. PubMed ID: 19366622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.
    Cong H; Gu QM; Jiang Y; He SY; Zhou HY; Yang TT; Li Y; Zhao QL
    Parasite Immunol; 2005; 27(1-2):29-35. PubMed ID: 15813720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immune response elicited by the recombinant protein and plasmid DNA of complex antigen ROP2-SAG1 from Toxoplasma gondii].
    Li WS; Xie ZX; Chen QX; Chen S; Zhang LF
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2010 Oct; 28(5):359-63. PubMed ID: 21351549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective immunity against Toxoplasma challenge in mice by coadministration of T. gondii antigens and Eimeria profilin-like protein as an adjuvant.
    Hedhli D; Dimier-Poisson I; Judge JW; Rosenberg B; Mévélec MN
    Vaccine; 2009 Apr; 27(16):2274-81. PubMed ID: 19428842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxoplasma gondii: DNA vaccination with genes encoding antigens MIC2, M2AP, AMA1 and BAG1 and evaluation of their immunogenic potential.
    Dautu G; Munyaka B; Carmen G; Zhang G; Omata Y; Xuenan X; Igarashi M
    Exp Parasitol; 2007 Jul; 116(3):273-82. PubMed ID: 17379212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxoplasma gondii: serological characterization and immunogenicity of recombinant surface antigen 2 (SAG2) expressed in the yeast Pichia pastoris.
    Lau YL; Fong MY
    Exp Parasitol; 2008 Jul; 119(3):373-8. PubMed ID: 18457835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the immune response elicited by multi-antigenic DNA vaccine expressing SAG1, ROP2 and GRA2 against Toxoplasma gondii.
    Xue M; He S; Cui Y; Yao Y; Wang H
    Parasitol Int; 2008 Dec; 57(4):424-9. PubMed ID: 18562245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combination of antigenic regions of Toxoplasma gondii microneme proteins induces protective immunity against oral infection with parasite cysts.
    Beghetto E; Nielsen HV; Del Porto P; Buffolano W; Guglietta S; Felici F; Petersen E; Gargano N
    J Infect Dis; 2005 Feb; 191(4):637-45. PubMed ID: 15655789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral and cellular immune responses in pigs immunized intranasally with crude rhoptry proteins of Toxoplasma gondii plus Quil-A.
    da Cunha IA; Zulpo DL; Bogado AL; de Barros LD; Taroda A; Igarashi M; Navarro IT; Garcia JL
    Vet Parasitol; 2012 May; 186(3-4):216-21. PubMed ID: 22137347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA vaccine encoding the Toxoplasma gondii bradyzoite-specific surface antigens SAG2CDX protect BALB/c mice against type II parasite infection.
    Zhang M; Zhao L; Song J; Li Y; Zhao Q; He S; Cong H
    Vaccine; 2013 Sep; 31(41):4536-40. PubMed ID: 23933373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxoplasma gondii: protective immunity against toxoplasmosis with recombinant actin depolymerizing factor protein in BALB/c mice.
    Huang X; Li J; Zhang G; Gong P; Yang J; Zhang X
    Exp Parasitol; 2012 Mar; 130(3):218-22. PubMed ID: 22248986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of B epitopes in GRA4, a dense granule antigen of Toxoplasma gondii and protection studies using recombinant proteins administered by the oral route.
    Mévélec MN; Mercereau-Puijalon O; Buzoni-Gatel D; Bourguin I; Chardès T; Dubremetz JF; Bout D
    Parasite Immunol; 1998 Apr; 20(4):183-95. PubMed ID: 9618729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oocyst shedding in cats vaccinated by the nasal and rectal routes with crude rhoptry proteins of Toxoplasma gondii.
    Zulpo DL; Headley SA; Biazzono L; da Cunha IA; Igarashi M; de Barros LD; Taroda A; Cardim ST; Bogado AL; Navarro IT; Garcia JL
    Exp Parasitol; 2012 Jun; 131(2):223-30. PubMed ID: 22542988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.